Bajaj Healthcare Ltd - 539872 - Board Meeting Intimation for Board Meeting To Be Held On 10Th July, 2024
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/07/2024 ,inter alia, to consider and approve 1. Proposed fund raising 2. Increase in Authorised share capital of the Company 3. Alteration in the Articles of Association of the Compay 4. Any other business Bajaj Healthcare Ltd - 539872 - Closure of Trading Window
The trading window for dealing in the equity shares of the Company is closed for all Insiders, Designated Persons and their immediate relatives from 1st July, 2024 up to the expiry of 48 hours post the declaration of unaudited financial results for the quarter ended 30th June, 2024. Bajaj Healthcare Ltd - 539872 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31st March, 2024 Bajaj Healthcare Ltd - 539872 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for audited financial results for the year ended March, 2024 Bajaj Healthcare Ltd - 539872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Revised press release dated 25th May, 2024 Bajaj Healthcare Ltd - 539872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Investor release for the quarter/year ended 31st March, 2024 Bajaj Healthcare Ltd - 539872 - Audited Results For FY Ended 31St March, 2024
Audited Results for FY ended 31st March, 2024 Bajaj Healthcare Ltd - 539872 - Board Meeting Outcome for Outcome Of Board Meeting Held On 24Th May, 2024
Outcome of Board Meeting held on 24th May, 2024 Bajaj Healthcare Ltd - 539872 - Corporate Action-Board to consider Dividend
Board to consider dividend at its meeting to be held on 24th May, 2024. Bajaj Healthcare Ltd - 539872 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled On 24/05/2024
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 ,inter alia, to consider and approve 1. Audited Financial Results for the quarter and year ended March 31, 2024. 2. Recommend final dividend on equity shares, if any, for the financial year ended March 31, 2024.